Bandaram Pharma Packtech Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|
Revenue | 2.72 | 1.52 | 5.70 |
Operating Expense | 2.97 | 1.53 | 5.63 |
Net Profit | -0.25 | -0.02 | 0.05 |
Net Profit Margin | -9.19 | -1.32 | 0.88 |
Earning Per Share | -0.21 | -0.01 | 0.04 |
EBIDTA | -0.25 | -0.01 | 0.07 |
Effective Tax Rate | TBA | TBA | 28.57 |
Particulars | Jun 2024 |
---|---|
Revenue | 2.72 |
Operating Expense | 2.97 |
Net Profit | -0.25 |
Net Profit Margin | -9.19 |
Earning Per Share | -0.21 |
EBIDTA | -0.25 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|
Total Revenue Annual | 10.09 | TBA | TBA |
Operating Expenses Annual | 9.82 | 0.01 | 0.01 |
Operating Profit Annual | 0.27 | -0.01 | -0.01 |
Interest Annual | 0.00 | 0.00 | TBA |
Depreciation | 0.00 | TBA | 0.02 |
Net Profit Annual | 0.20 | -0.01 | -0.03 |
Tax Annual | 0.07 | TBA | TBA |
Particulars | Mar 2023 |
---|---|
Total Revenue Annual | 10.09 |
Operating Expenses Annual | 9.82 |
Operating Profit Annual | 0.27 |
Interest Annual | 0.00 |
Depreciation | 0.00 |
Net Profit Annual | 0.20 |
Tax Annual | 0.07 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|
Cash Flow at the Beginning | 2.08 | TBA | TBA |
Cash Flow from Operations | -3.87 | 2.92 | TBA |
Cash Flow from Investing | -2.53 | -1.55 | TBA |
Cash Flow from Financing | 4.40 | 0.72 | TBA |
Cash Flow at the End | 0.09 | 2.08 | TBA |
Particulars | Mar 2023 |
---|---|
Cash Flow at the Beginning | 2.08 |
Cash Flow from Operations | -3.87 |
Cash Flow from Investing | -2.53 |
Cash Flow from Financing | 4.40 |
Cash Flow at the End | 0.09 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|
PBDIT Margin (%) | 2.68 | TBA | TBA |
PBIT Margin (%) | 2.68 | TBA | TBA |
PBT Margin (%) | 2.68 | TBA | TBA |
Net PROFIT Margin (%) | 1.98 | TBA | TBA |
Return On Networth / Equity (%) | 6.60 | TBA | TBA |
Return On Networth /Employed (%) | 5.16 | TBA | TBA |
Return On Assets (%) | 3.83 | TBA | TBA |
Total Debt / Equity (X) | 0.73 | 2.17 | TBA |
Asset Turnover Ratio (%) | 1.93 | TBA | TBA |
Particulars | Mar 2023 |
---|---|
PBDIT Margin (%) | 2.68 |
PBIT Margin (%) | 2.68 |
PBT Margin (%) | 2.68 |
Net PROFIT Margin (%) | 1.98 |
Return On Networth / Equity (%) | 6.60 |
Return On Networth /Employed (%) | 5.16 |
Return On Assets (%) | 3.83 |
Total Debt / Equity (X) | 0.73 |
Asset Turnover Ratio (%) | 1.93 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|
Fixed Assets Annual | 0.02 | TBA | 0.11 |
Total Current Assets Annual | 5.74 | 3.00 | 0.77 |
Non Current Assets Annual | 2.53 | TBA | 0.50 |
Total Shareholders Funds Annual | 3.07 | 2.99 | -2.32 |
Total Assets Annual | 8.27 | 3.00 | 1.26 |
Particulars | Mar 2023 |
---|---|
Fixed Assets Annual | 0.02 |
Total Current Assets Annual | 5.74 |
Non Current Assets Annual | 2.53 |
Total Shareholders Funds Annual | 3.07 |
Total Assets Annual | 8.27 |
EPS (INR)
Expected
0.15
Reported
0.15
Surprise
0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
Sep 2023
EPS beaten by 0.00%